Publications by authors named "Stephanie Geisler"

Claim this Profile
T
The impact of functional MDM2-polymorphisms on neutrophil counts in breast cancer patients during neoadjuvant chemotherapy.
Nora D Hatletvedt, Christina Engebrethsen, Jürgen Geisler, Stephanie Geisler, Turid Aas

BMC Cancer· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The NEOLETRIB trial: neoadjuvant treatment with Letrozole and Ribociclib in ER-positive, HER2-negative breast cancer.
Kamilla Fjermeros, Salim Ghannoum, Stephanie B Geisler, Sameer Bhargava, Andliena Tahiri, Jürgen Geisler

Future Oncol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Superior suppression of serum estrogens during neoadjuvant breast cancer treatment with letrozole compared to exemestane.
Bjørn-Erik Bertelsen, Bjørg Almås, Kamilla Fjermeros, Kristin Viste, Stephanie Beate Geisler, Jürgen Geisler

Breast Cancer Res Treat· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prenatal BRCA1 epimutations contribute significantly to triple-negative breast cancer development.
Oleksii Nikolaienko, Hans P Eikesdal, Elisabet Ognedal, Bjørnar Gilje, Steinar Lundgren, Jürgen Geisler, Stephanie Geisler

Genome Med· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of humans versus mobile phone-powered artificial intelligence for the diagnosis and management of pigmented skin cancer in secondary care: a multicentre, prospective, diagnostic, clinical trial.
Scott W Menzies, Christoph Sinz, Michelle Menzies, Serigne N Lo, William Yolland, Stephanie Geisler

Lancet Digit Health· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clonal evolution in primary breast cancers under sequential epirubicin and docetaxel monotherapy.
Andreas Venizelos, Christina Engebrethsen, Wei Deng, Jürgen Geisler, Stephanie Geisler

Genome Med· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lack of cross-resistance between non-steroidal and steroidal aromatase inhibitors in breast cancer patients: the potential role of the adipokine leptin.
Nazli Bahrami, Shakila Jabeen, Andliena Tahiri, Torill Sauer, Hilde Presterud Ødegård, Stephanie Beate Geisler, Jürgen Geisler

Breast Cancer Res Treat· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Iliofemoral tortuosity score predicts access and bleeding complications during transfemoral transcatheter aortic valve replacement: DataData from the VIenna Cardio Thoracic aOrtic valve registrY (VICTORY).
Markus Mach, Thomas Poschner, Waseem Hasan, Philipp Szalkiewicz, Martin Andreas, Stephanie Geisler, Daniela Geisler

Eur J Clin Invest· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A rare case of a subungual epidermoid cyst treated by surgical excision maintaining maximal functionality.
Stephanie Geisler, Volker Steinkraus, Christoph R Loeser

JAAD Case Rep· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The NEOLETEXE trial: a neoadjuvant cross-over study exploring the lack of cross resistance between aromatase inhibitors.
Nazli Bahrami, Torill Sauer, Siri Engebretsen, Belal Aljabri, Vahid Bemanian, Stephanie Beate Geisler, Jürgen Geisler

Future Oncol· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Short-Term Efficacy of Trichloroacetic Acid in the Treatment of Cervical Intraepithelial Neoplasia.
Stephanie Geisler, Sophie Speiser, Lukas Speiser, Georg Heinze, Adam Rosenthal

Obstet Gynecol· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Concomitant inactivation of the p53- and pRB- functional pathways predicts resistance to DNA damaging drugs in breast cancer in vivo.
Stian Knappskog, Elisabet O Berge, Ranjan Chrisanthar, Stephanie Geisler, Vidar Staalesen

Mol Oncol· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical efficacy and safety of bevacizumab monotherapy in patients with metastatic melanoma: predictive importance of induced early hypertension.
Cornelia Schuster, Hans P Eikesdal, Hanne Puntervoll, Jürgen Geisler, Stephanie Geisler

PLoS One· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification and characterization of retinoblastoma gene mutations disturbing apoptosis in human breast cancers.
Elisabet Ognedal Berge, Stian Knappskog, Stephanie Geisler, Vidar Staalesen, Marec Pacal

Mol Cancer· July 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
DNA methylation profiling in doxorubicin treated primary locally advanced breast tumours identifies novel genes associated with survival and treatment response.
Emelyne Dejeux, Jo Anders Rønneberg, Hiroko Solvang, Ida Bukholm, Stephanie Geisler

Mol Cancer· March 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A mitochondrial target sequence polymorphism in manganese superoxide dismutase predicts inferior survival in breast cancer patients treated with cyclophosphamide.
Sharon A Glynn, Brenda J Boersma, Tiffany M Howe, Hege Edvardsen, Stephanie B Geisler

Clin Cancer Res· June 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular dissection of ODF2/Cenexin revealed a short stretch of amino acids necessary for targeting to the centrosome and the primary cilium.
Daniela Hüber, Stephanie Geisler, Sebastian Monecke, Sigrid Hoyer-Fender

Eur J Cell Biol· March 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ABCB1 and GST polymorphisms associated with TP53 status in breast cancer.
Silje H Nordgard, Marylyn D Ritchie, Sigrid D Jensrud, Alison A Motsinger, Grethe I G Alnaes, Stephanie Geisler

Pharmacogenet Genomics· February 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gene expression profiles do not consistently predict the clinical treatment response in locally advanced breast cancer.
Therese Sørlie, Charles M Perou, Cheng Fan, Stephanie Geisler, Turid Aas

Mol Cancer Ther· November 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expression of full-length p53 and its isoform Deltap53 in breast carcinomas in relation to mutation status and clinical parameters.
Lars O Baumbusch, Simen Myhre, Anita Langerød, Anna Bergamaschi, Stephanie B Geisler

Mol Cancer· October 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The murine Dnali1 gene encodes a flagellar protein that interacts with the cytoplasmic dynein heavy chain 1.
Sajid Rashid, Rolf Breckle, Mike Hupe, Stephanie Geisler, Nadine Doerwald

Mol Reprod Dev· June 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic and predictive value of changes in tumour cell proliferation in locally advanced breast cancer primarily treated with doxorubicin.
Turid Aas, Stephanie Geisler, Hildegunn Helle, Anne-Lise Børresen-Dale, Per Eystein Lønning

Oncol Rep· March 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Alternative splicing and mutation status of CHEK2 in stage III breast cancer.
Vidar Staalesen, Jacob Falck, Stephanie Geisler, Jirina Bartkova, Anne-Lise Børresen-Dale

Oncogene· November 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TP53 gene mutations predict the response to neoadjuvant treatment with 5-fluorouracil and mitomycin in locally advanced breast cancer.
Stephanie Geisler, Anne-Lise Børresen-Dale, Hilde Johnsen, Turid Aas, Jürgen Geisler

Clin Cancer Res· November 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Repeated observation of breast tumor subtypes in independent gene expression data sets.
Therese Sorlie, Robert Tibshirani, Joel Parker, Trevor Hastie, J S Marron, Stephanie Geisler

Proc Natl Acad Sci U S A· July 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis